Back

Convergent strategies for nanobody-mediated inhibition of an epoxide hydrolase

Simard, A. R.; Taher, N. M.; Beauchemin, K. S.; Mishra, A. K.; Hederman, A. P.; Hampton, T. H.; Vasylieva, N.; Morisseau, C.; Ackerman, M. E.; Madden, D. R.

2026-02-10 biochemistry
10.64898/2026.02.09.704437 bioRxiv
Show abstract

Secreted by Pseudomonas aeruginosa, Cif is an epoxide hydrolase that acts as a virulence factor in the context of cystic fibrosis and thus represents a target for therapeutic inhibition. Here, we present the structures of several high-affinity inhibitory nanobodies, each bound to Cif. Comparison reveals two classes of nanobodies with distinct CDR sequences and convergent recognition strategies. Mimicry between CDR3 and CDR2 loops positions an aromatic residue for insertion through the active-site gate, accessing a cryptic epitope, which sterically blocks substrate access and provides an anchor point for high-affinity engagement. Projection of either inhibitory CDR toward the active-site entrance requires a relative 90{degrees} rotation of the core immunoglobulin domain, and yet both classes engage the same set of stereochemical handholds within a highly overlapping shared epitope. The structurally distinct paratopes thus represent fundamentally distinct solutions, reflecting the remarkable capacity of the immune system to solve highly constrained molecular recognition challenges.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.